Latest Articles

Technology Networks recently interviewed Prof. Mick Bhatia, from McMaster University, to learn more about his research focused on the role of abnormal dopamine receptor pathway activation in adult patients with acute myeloid leukemia (AML).

One of the first things to strike you when studying neuroanatomy is the dizzying amount of jargon. Our brain’s incredible complexity has seen generations of neuroscientists build up an exhaustive list of terminology for different brain regions and cell types. In this article, we explain the terminology used to denote directions in the nervous system.

Neurological disorders affect a significant proportion of the population and approximately 47% of individuals have concurrent mental health issues. How can we better help better recover from these disorders? This review takes a look at the strengths and weaknesses of one classification system.

Subliminal messaging – we’ve all heard about it. But it doesn’t really work, right? New research from Valentin Dragoi’s lab at the University of Texas at Houston suggests that subliminal images can change our brain activity and behavior.

We recently interviewed Dr Peter Nemes to learn how his lab is "digging in a goldmine of discoveries" in developmental biology, what the future of MS-based analysis might hold and the challenges that come with probing the molecules of life that only exist for a matter of minutes.

Cell culture contamination is a major concern for biological and biomedical research, as well as for biologics therapeutics production. Here, we take a closer look at mycoplasma contamination and problematic cell lines.

When it comes to analyzing cells in a lab setting, flow cytometry is a widely used and comprehensive single-cell analysis method. This article outlines what flow cytometry is, how it works, the different types that exist, how data are analyzed, and what the future holds for flow cytometry.

Historically, efforts to target the substance P (SP) neurokinin 1 receptor (NK1R), for the treatment of pain have failed. These studies had one critical flaw, whilst they were targeting the right receptor, they were focusing on the wrong location.

Historically, the mental health industry has been slow in the adoption of technology; however, over the past few years, we have seen a growing need to boost technology’s role in mental health treatment, driven by growing barriers to entry such as shortage of appropriate staff, cost and location. But what kind of treatment will drive us forward?

A new study found that traumatic experiences in early life cause changes in the blood composition – namely metabolites – that are passed on to the next generation. Technology Networks spoke with Professor Isabelle Mansuy, the study leader, to find out more.